Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma

Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma

Chimeric antigen receptor (CAR) T cell therapy has become a new mainstay in the treatment of several hematologic malignancies, but the spectrum of associated complications is still incompletely defined. Here, we report the case of a 70-year-old female patient treated with tisagenlecleucel for diffus...

Full description

Bibliographic Details
Main Authors: Sebastian Zundler, Francesco Vitali, Soraya Kharboutli, Simon Völkl, Iris Polifka, Andreas Mackensen, Raja Atreya, Markus F. Neurath, Dimitrios Mougiakakos
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
diffuse large B cell lymphoma
inflammatory bowel disease (IBD)
tisagenlecleucel
case report
CAR T cells
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1149450/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1149450/full

Similar Items